Lords Mark Industries Limited
Lords Mark Industries Q1 FY27: Revenue ₹3000 Cr, EBITDA margin 20%
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
The short version
Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28. Lords Mark Industries expects to cross ₹2000 crores in total revenue by FY28.
From Lords Mark Industries Limited's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28.
- Medtech segment, including products under development like dialysis machines, Onco Diagnoscope, Onco TB Truth, Onco Spot, and sickle cell testing, is expected to contribute at least 30% to total revenue.
- The company anticipates launching these new Medtech products by Q4 FY27 or early FY28, targeting large addressable markets such as preventive healthcare and cancer diagnosis.
- Renewable energy maintains a ₹3000 crore order book, providing steady revenue alongside the higher margin Medtech business.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Lords Mark Industries Limited said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Lords Mark Industries is currently not capital-intensive in manufacturing; they use OEM partners like BEL to manufacture dialysis machines to avoid heavy capex initially.
- The company plans to scale production internally and may set up their own manufacturing capex once the business stabilizes.
- No specific future capex figures or major strategic capital investments were disclosed in the transcript.
- Focus is on adding and developing new technologies/products acquired from government institutions rather than heavy immediate capital investment.
2 more points management made on capital expenditure plans
Top-ranked in Commercial Services & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Lords Mark Industries Limited said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The current order book in the renewable energy and LED business is around ₹3,000 crores.
- The dialysis machine segment has an order book of over 500 machines, covering both domestic and export markets.
- The company has a decent order book to be executed in renewable energy, including rooftop solar projects under the RESCO model with UPNEDA and BREDA at a profitable tariff of ₹4.95 per unit.
- The renewable energy order book stands firm at around ₹3,000 crores as of the latest update.
2 more points management made on order book & pipeline
Continue your research
What Lords Mark Industries's management said in earlier quarters
Others in Commercial Services & Supplies this season
- IIRM Holdings India Ltd (Q1 FY27)
Revenue from operations for Q1 FY27: ₹735.0 million, up 8.1% YoY (Page 9) . Key concall takeaways from IIRM Holdings India Ltd's Q1 FY27 earnings call — and…
- NDR INVIT Trust (Q1 FY27)
Year-on-year revenue growth: ~22% (calculated from INR 1,240.21 mn vs INR 1,015.59 mn) (Pages 12 and 14) . Key concall takeaways from NDR INVIT Trust's Q1 FY27…
- Indiabulls Limited (Q1 FY27)
Q1FY27 Revenue: ₹384.4 Cr (Page 5) . Key concall takeaways from Indiabulls Limited's Q1 FY27 earnings call — and how it ranks against sector peers.
- Creative Newtech Ltd (Q1 FY27)
Consolidated Revenue from Operations for Q1 FY27: ₹476.07 crore, up from ₹392.96 crore in Q1 FY26 (YoY growth approximately 21.12%). Key concall takeaways from…
Frequently Asked Questions
What were Lords Mark Industries Limited Q1 FY27 results?
Lords Mark Industries expects over 20% year-on-year revenue growth, with top-line projected to exceed ₹2000 crores by FY28. Lords Mark Industries expects to cross ₹2000 crores in total revenue by FY28.
What is Lords Mark Industries Limited share price analysis?
Lords Mark Industries Limited currently shows a neutral. The stock trades at a P/E of 44.7 with a market cap of ₹3,797 Cr. Investors should review the full earnings analysis for detailed insights.
Is Lords Mark Industries Limited planning capital expenditure?
Lords Mark Industries is currently not capital-intensive in manufacturing; they use OEM partners like BEL to manufacture dialysis machines to avoid heavy capex initially.
Keep Lords Mark Industries Limited on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.